17:11 EST Crescent Biopharma (CBIO) files to sell 19.71M shares of common stock for holders
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CBIO:
- Crescent Biopharma: Advancing De-Risked Immuno-Oncology Pipeline and Strategic Partnerships Underscore Undervalued Buy Opportunity
- Crescent Biopharma announces regulatory clearance of IND applications
- Two new option listings and eighteen option delistings on December 22nd
- Crescent Biopharma’s Strategic Growth and Competitive Edge Justify Buy Rating
- Crescent Biopharma price target raised to $32 from $28 at Stifel